Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

N. Takigawa, K. Kiura, Y. Segawa, Y. Watanabe, H. Kamei, T. Moritaka, T. Shibayama, H. Ueoka, K. Gemba, T. Yonei, M. Tabata, T. Shinkai, S. Hiraki, M. Takemoto, S. Kanazawa, K. Matsuo, M. Tanimoto

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

Original languageEnglish
Pages (from-to)1142-1144
Number of pages3
JournalBritish Journal of Cancer
Volume95
Issue number9
DOIs
Publication statusPublished - Nov 6 2006

Keywords

  • Chemotherapy
  • Non-small-cell lung cancer
  • Radiotherapy
  • Second primary cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Takigawa, N., Kiura, K., Segawa, Y., Watanabe, Y., Kamei, H., Moritaka, T., Shibayama, T., Ueoka, H., Gemba, K., Yonei, T., Tabata, M., Shinkai, T., Hiraki, S., Takemoto, M., Kanazawa, S., Matsuo, K., & Tanimoto, M. (2006). Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. British Journal of Cancer, 95(9), 1142-1144. https://doi.org/10.1038/sj.bjc.6603422